Evidence · 6 min read
Creatine and the brain: the energy case gets stronger
New 2026 brain-imaging trials show 5 g/day of creatine raises the brain's own energy reserve and may slow early Alzheimer's decline. The signal is real and worth watching — but still early, and not a treatment claim.
By KÖGN Editorial · ·
Key takeaways
- Creatine's evidence has long been strongest for muscle; in 2026 the case for the brain moved forward, not just the body.
- University of Kansas Medical Center trials using brain imaging (MRS) found 5 g/day lifted the brain's phosphocreatine — its rapid energy buffer — by roughly 10–15%, and that the energy gain tracked modest short-term memory improvement.
- In an early-Alzheimer's group, the same dose was associated with cognitive decline slowing by around 30% over the study window.
- This is preliminary: small, early-stage trials, not a treatment. It strengthens an existing hypothesis rather than settling it.
What's new
Creatine is one of the most-studied supplements there is, but almost all of that depth sits on the muscle side. The interesting shift in 2026 is that the brain evidence — long thesis, thin data — finally has better measurements behind it.
Researchers at the University of Kansas Medical Center used magnetic resonance spectroscopy (MRS), a scan that reads the chemistry inside living tissue, to look directly at the brain rather than inferring from test scores alone. That's the part worth paying attention to: they measured the mechanism, not just the outcome.
What the trials found
At 5 g/day — the same maintenance dose used for muscle — the scans showed brain phosphocreatine rising by roughly 10–15%. Phosphocreatine is the brain's fast-access energy buffer, the reserve neurons draw on when demand spikes, so a measurable rise is a plausible route to a real effect rather than a hopeful one.
The energy gain didn't stay abstract. It tracked a modest improvement in short-term memory, which is the kind of coherent picture — dose, mechanism, and outcome pointing the same way — that separates a promising finding from a noisy one.
The headline number came from an early-Alzheimer's group, where 5 g/day was associated with cognitive decline slowing by about 30% over the study window. That is a striking figure, and exactly the sort of result that needs larger, longer trials before anyone leans on it.
How much weight to put on it
Honestly: some, not all. These are early-stage trials — small groups, short windows — and "slows decline in a study" is not the same as "treats Alzheimer's." Creatine is not a therapy for dementia, and nothing here changes that.
What it does do is move creatine's brain case from mechanism-and-hope toward mechanism-and-measurement. For a healthy adult already taking creatine for training, a possible cognitive upside is a reasonable bonus to expect — not the reason to start, and not a substitute for sleep, exercise, or medical care.
It's also a reminder of why dose and study quality decide everything. The brain effects showed up at the same unglamorous 5 g/day that works for muscle — not at some exotic amount — which is precisely why the finding is credible enough to follow.
Put it into practice
See your own afternoon, mapped — and the single capsule built for the 3pm slump.
Educational information, not medical advice. Speak to a qualified clinician before changing what you take.